Selective activation of apoptosis by a novel set of 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1H)-quinolinones through a Myc-dependent pathway

被引:70
作者
Claassen, Gisela [1 ]
Brin, Elena [1 ]
Crogan-Grundy, Candace [1 ]
Vaillancourt, Mei Ting [1 ]
Zhang, Han Zhong [1 ]
Cai, Sui Xiong [1 ]
Drewe, John [1 ]
Tseng, Ben [1 ]
Kasibhatla, Shailaja [1 ]
机构
[1] EpiCept Corp, Dept Biol, San Diego, CA 92121 USA
关键词
Caspases; Effectors of apoptosis; Oncogenes; Myc; Small molecule drugs; CHRONIC MYELOID-LEUKEMIA; C-MYC; BCR-ABL; MYC/MAX DIMERIZATION; TYROSINE KINASE; SMALL MOLECULES; TRANSFORMATION; PROTEOLYSIS; PROTEASOME; EXPRESSION;
D O I
10.1016/j.canlet.2008.09.032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oncogene addiction due to Myc deregulation has been identified in a variety of tumor types. In order to identify pharmacological agents that cause selective apoptosis in tumors with deregulated Myc expression, we designed a cell-based screening assay based on our Anti-cancer Screening Apoptosis Program (ASAP) technology targeting increased activity in a "Myc-addicted" cancer cell panel. We have identified a novel set of substituted 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1H)-quinolinones that activates apoptosis in cancer cell lines with deregulated Myc, but show low activity in cell lines where Myc is not deregulated. Apoptosis induced by these compounds is rapid, and is associated with a significant downregulation of Myc protein. Selective knockdown of Myc levels in these cells by RNA interference increased sensitivity to apoptosis with compound treatment. By targeting the Myc pathway in Myc-addicted cancer cells, we have identified a novel class of apoptotic inducers that selectively and efficiently target cancer cells with deregulated Myc. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 41 条
[1]   ALTERATIONS IN THE P53 GENE AND THE CLONAL EVOLUTION OF THE BLAST CRISIS OF CHRONIC MYELOCYTIC-LEUKEMIA [J].
AHUJA, H ;
BARELI, M ;
ADVANI, SH ;
BENCHIMOL, S ;
CLINE, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6783-6787
[2]  
AVRANITIS C, 2005, CANC LETT, V226, P95
[3]   c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover [J].
Bahram, F ;
von der Lehr, N ;
Cetinkaya, C ;
Larsson, LG .
BLOOD, 2000, 95 (06) :2104-2110
[4]   Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts [J].
Berg, T ;
Cohen, SB ;
Desharnais, J ;
Sonderegger, C ;
Maslyar, DJ ;
Goldberg, J ;
Boger, DL ;
Vogt, PK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :3830-3835
[5]   Translocations involving c-myc and c-myc function [J].
Boxer, LM ;
Dang, CV .
ONCOGENE, 2001, 20 (40) :5595-5610
[6]   Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay [J].
Cai, SX ;
Zhang, HZ ;
Guastella, J ;
Drewe, J ;
Yang, W ;
Weber, E .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (01) :39-42
[7]   ALTERED EXPRESSION OF G1-SPECIFIC GENES IN HUMAN-MALIGNANT MYELOID CELLS [J].
CALABRETTA, B ;
VENTURELLI, D ;
KACZMAREK, L ;
NARNI, F ;
TALPAZ, M ;
ANDERSON, B ;
BERAN, M ;
BASERGA, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (05) :1495-1498
[8]   Mitochondria as the central control point of apoptosis [J].
Desagher, S ;
Martinou, JC .
TRENDS IN CELL BIOLOGY, 2000, 10 (09) :369-377
[9]   Mechanistic studies on the inactivation of the proteasome by lactacystin A central role for clasto-lactacystin beta-lactone [J].
Dick, LR ;
Cruikshank, AA ;
Grenier, L ;
Melandri, FD ;
Nunes, SL ;
Stein, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) :7273-7276
[10]   Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].
Druker, BJ ;
Talpaz, M ;
Resta, DJ ;
Peng, B ;
Buchdunger, E ;
Ford, JM ;
Lydon, NB ;
Kantarjian, H ;
Capdeville, R ;
Ohno-Jones, S ;
Sawyers, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037